v3 Template
H

Hangzhou Diagens Biotechnology Co., Ltd.

Biotechnology and Healthcare
Founded
--
Employees
--
Total Funding
$101.0M
Funding Rounds
1
Last Funding
2026-03-31

About Hangzhou Diagens Biotechnology Co., Ltd.

Hangzhou Diagens Biotechnology Co., Ltd. is a company focused on intelligent medical device products and AI-driven health solutions, aiming to advance medical diagnostics and research through innovative technology in cytogenetics and medical imaging.

Products & Services

AIAutoVision(r) Chromosome Karyotype Assisted Diagnosis System:An AI-powered system for assisting in chromosome karyotype diagnosis.
MetaSight(r) Automatic Cell Microscopic Image Scanning System:An automated system for scanning microscopic cell images.
KayoFlow(r) Cytogenetics Automatic Cell Harvester:An automated cell harvester for cytogenetics applications.
KayoFlow(r) Integrated Slide Preparation and Staining System:A system for preparing and staining slides in cytogenetics workflows.
KayoFlow(r) Workflow:A comprehensive workflow solution for cytogenetics processes.
Cytogenetics Laboratory Reagents and Consumables:Reagents and consumables for cytogenetics laboratories.
Integrated Storage, Computation, Training and Inference Localized Solution:A localized solution for storage, computation, training, and inference in medical applications.
iMed MaaS Medical Imaging AI Platform:An AI platform for medical imaging services.
AI-Driven Genetics Health Solutions:AI-based solutions for genetics health applications.
iMedImage(r) Based Model Service Portfolio:A portfolio of model services based on iMedImage technology for research purposes.

Specialties

AI-Driven Medical Diagnostics Cytogenetics Medical Imaging Chromosome Karyotype Analysis Genetics Health Solutions Radiological Health Solutions Hematology Solutions

Funding History

Debug: View Raw Funding Data
# Type Amount Fields Date Fields Investors
1 RT: IPO
T: -
FT: IPO
A: 101000000
MR: -
FA: US$101 million
FAN: 101000000
D: 2026-03-31
FD: 2026-03-31
-
IPO Latest
2026-03-31
$101.0M

Growth Metrics

+45%
Employee Growth
YoY
3.2x
Funding Growth
Last Round
12
Markets
Operating
10K+
Customers
Active

View 3 more growth metrics with Pro

Unlock All Metrics
Mock Up

Team & Leadership

No team data available

Team information is not yet available for this company

Recent News

Hangzhou Diagens Biotechnology Co., Ltd. Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Read more →

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Read more →

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Read more →

View 2 more news articles with Pro

Unlock Full News Feed
Mock Up

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised

Mock Up

Company Details

Industries
Biotechnology and Healthcare

Similar Companies

Discover AI-powered company recommendations based on industry, funding, and team profiles.

Upgrade to Pro

Technology Stack

Discover the backend, frontend, and infrastructure technologies powering this company's products.

Upgrade to Pro